Key African Anti-Venom About to Permanently Run Out

It sounds like a tale of corporate greed: A particularly effective African anti-venom soon will be completely unavailable because its manufacturer decided it was not profitable. Remaining stocks of the drug expire at the end of June. The situation has prompted aid groups like Doctors Without Borders to sound the alarm over the imminent shortage of Fav-Afrique, which treats bites from 10 types of snakes.   “We are upset about the decision of Sanofi Pasteur to stop Fav-Afrique...

© La Voix de l'Amérique - vendredi 24 juin 2016